BL
BioLife Solutions, Inc.
BLFS · NASDAQ
$36.69 -0.11% (-$0.04)
1M -1.34%
Market Cap $1.79B
P/E Ratio 35.53x
Div. Yield -
ROE 13.29%
Bulios Fair Price
$22.45
38.8% downside
Trenutna cena
$36.69
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica BLFS trenutno precenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Moderate
5/9Valuation
12 /100
Expensive EV/EBITDA 182.41x
P/S 17.43x
P/B 4.27x
Growth
52 /100
Stable Book val. growth 0.70%
Rev. growth 8.07%
FCF growth N/A
Profitability
49 /100
Moderate Net margin 49.06%
Op. margin 7.25%
FCF margin 0.88%
Quality
59 /100
Average ROE 13.29%
ROA 11.27%
Asset turnover 0.23x
Debt
97 /100
Low Current ratio 9.69x
Int. coverage 9.40x
Net debt/EBITDA -0.84x
Stability
60 /100
Moderate Rev. volatility 8.74%
EPS volatility 14.07%
Profitable years 0
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o BLFS
Online
Sector
Healthcare
Industry
Medical - Instruments & Supplies
CEO
Roderick de Greef
Employees
155
Headquarters
Bothell
Prihajajoči dogodki
05 NOV.
Earnings
Upcoming earnings report